Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • JAMA Sub-Journal丨Breast Cancer Incidence Following False-Positive Mammogram Results

    Mammography is the only imaging method proven to detect breast cancer early and reduce patient mortality; however, traditional mammography often yields false-positive results, and the long-term outcomes of these false positives remain unclear. Recently, a Swedish study involving 497,343 women found that the risk of breast cancer following a false-positive mammogram varies based on personal…

    2024.08.09
  • Leading Experts Discuss Current and Future Immunotherapy for TNBC, Guiding Precision Treatment Development丨2024 Breast Cancer Summer Forum·

    On July 27-28, 2024, the “2024 Breast Cancer Summer Forum·Northern Salon” was grandly held at the Shougang Park in Beijing. The conference adhered to the concept of “learning, absorbing, innovating, and improving” and embraced the tradition of “All directions, Throughout time and across the world, Across all seasons, People of all ages and genders” offering…

    2024.08.09
  • Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting 🌟 | Real-World Exploration and AI Applications in Prostate Cancer Pathology

    Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the treatment of prostate cancer. “Oncology Frontier” invited…

    2024.08.09
  • Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting (Real-World Exploration and Learning from Others)

    Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the treatment of prostate cancer. “Oncology Frontier” invited…

    2024.08.09
  • 2024 COMB丨Dr. Fei Ma: Metronomic Chemotherapy Combined with Immunotherapy Opens a New Chapter in Breast Cancer Research

    In the field of breast cancer treatment, innovative therapies are emerging constantly, yet many issues still urgently need to be addressed. Recently, Academician Binghe Xu and Dr. Fei Ma from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College published an article in Nature Medicine titled “Metronomic chemotherapy plus anti-PD-1…

    2024.08.09
  • Dr. Fu Fu Zheng: New Advances in Prostate Cancer Research at the 2024 ASCO Meeting (Real-World Exploration and Learning from Others)

    Prostate cancer is a common malignant tumor of the reproductive system, particularly affecting elderly men. Screening high-risk populations and tailoring treatment plans based on patient characteristics are crucial for improving cure rates and enhancing quality of life. Recently, the 2024 ASCO Annual Meeting unveiled numerous advancements in the treatment of prostate cancer. “Oncology Frontier” invited…

    2024.08.09
  • 2024 COMB丨Dr. Tao Sun: Progress in HER2+ EBC Treatment—De-escalation Therapy and the Prospects of ctDNA Application

    In recent years, the field of breast cancer treatment has seen a series of innovative research advancements, particularly in the treatment of HER2+ early breast cancer (EBC). Strategies such as “de-escalation,” “chemotherapy-free,” and “precision treatment” have become hot topics. At the 7th Precision Diagnosis and Treatment of Tumors and the 10th Individualized Treatment of Breast…

    2024.08.09
  • 🎙️ ASCO-GU Interview | Dr. Neal D. Shore: Examining Outcomes of Men with High-Risk Biochemically Recurrent Prostate Cancer Who Suspended Enzalutamide Monotherapy Treatment in the Phase 3 EMBARK Study. 🔍

    2024.08.09
«previous next»
Recent Posts
  • the 14th Lu Daopei Hematology Forum | Professor Xingyu Cao: Precision Risk Stratification, Optimized Strategies — Advances and Strategies in Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes
  • Roundtable · Moments in Time | Hematology Experts from Mainland China, Taiwan, Hong Kong and Macao: Looking Back on Cross-Regional Exchange, Carrying Forward a Shared Legacy, and Shaping a Future of Collaboration
  • Professor Hou Hsin-An: Deepening Cross-Strait Hematology Exchange and Exploring New Pathways for Precision Diagnosis and Treatment | 2026 Cross-Strait Hematology Conference
  • the 14th Lu Daopei Hematology Forum丨Dr. Chen Man: Immune Monitoring for Precise Differentiation — Clinical Applications of Lymphocyte Subset Analysis in Transplantation Complications
  • Professor Zhang Xiaohui Elected Vice Chair-Elect of the Hematology Branch of the Chinese Medical Association
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top